BENEVICH ERIC (CIK 1643653) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-15). Recent activity: Buy NBIX (6,275 shares), Sell NBIX (3,386 shares), Buy NBIX (3,194 shares), Sell NBIX (2,154 shares), Buy NBIX (2,005 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 6,275 | $0 |
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 3,386 | $528,961 |
| 2026-09-10 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 3,194 | $138,109 |
| 2026-09-10 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 2,154 | $333,030 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 2,005 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,082 | $133,194 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 1,961 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,058 | $131,319 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 2,083 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,124 | $139,511 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 16,613 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 8,963 | $1.1M |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 2,294 | $0 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 1,292 | $175,790 |
| 2026-01-16 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 12,830 | $461,752 |
| 2025-12-02 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Buy | 5,970 | $214,860 |
| 2025-12-02 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Commercial Officer | Sell | 5,970 | $905,888 |
Source: SEC Form 4 filings · as of 2026-09-15